trending Market Intelligence /marketintelligence/en/news-insights/trending/jd0IQ-XDJgBZePSZaYCKGg2 content esgSubNav
In This List

Eleven Biotherapeutics receives Nasdaq noncompliance notice

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Eleven Biotherapeutics receives Nasdaq noncompliance notice

Eleven Biotherapeutics Inc. received a notice from the Nasdaq Stock Market LLC for failing to meet the $1 minimum bid price listing requirement.

The company has 180 days or until June 11, 2018, to regain compliance.

To regain compliance, the closing bid price of the company's common stock must meet or exceed $1 per share for a minimum of 10 consecutive business days during the 180-day period.